Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Sensus lands Health Canada nod for its skin cancer system

November 23, 2012 2:29 pm | by Mass Device | News | Comments

Sensus Healthcare won Health Canada approval for its device for non-surgical skin cancer treatment, following wins in the U.S. and the U.K. Sensus Healthcare landed Health Canada approval for its SRT-100, a therapy device designed to non-surgically treat skin cancer in hospitals and private practice settings. The SRT-100 system features the company's SharpBeam characteristics, treating targeted lesions while leaving surrounding healthy tissue intact. The device treats non-melanoma skin cancer, providing virtually pain-free treatment according to the press release. News Well, CE Mark, Oncology, Regulatory/Complianceread more

Veryan lands CE Mark for its BioMimics 3D stent

November 23, 2012 1:29 pm | by Mass Device | News | Comments

U.K. medical device company Veryan receives CE Mark approval in European Union to market its BioMimics 3D stent. Vascular devices maker Veryan landed CE Mark approval for its BioMimics 3D stent, a device designed to treat superficial femoral and proximal popliteal arteries of the leg. The BioMimics 3D stent, which features a 3-dimensional design, can mimic the natural shape of the human vascular system to reduce kinking, deformation, and consequential vessel trauma during leg flexion, according to a press release. News Well, CE Mark, Regulatory/Compliance, Stentsread more

Report: Baxter trying to buy Swedish device maker

November 23, 2012 12:36 pm | by The Associated Press | News | Comments

Drug and medical device maker Baxter International Inc. is negotiating to buy Gambro AB, a Swedish maker of medical equipment, according to a report in the Wall Street Journal. The two companies are seeking to finalize a deal worth approximately $4 billion in the next few weeks, the newspaper...

Advertisement

Cordis unveils 1-year results for its Incraft AAA stent graft system

November 23, 2012 12:29 pm | by Mass Device | News | Comments

Johnson & Johnson's Cordis subsidiary touts positive 1-year findings for its Incraft AAA stent graft system in treatment of patients with abdominal aortic aneurysms. Johnson & Johnson (NYSE:JNJ) subsidiary Cordis this month unveiled 1-year clinical findings from a study of its Incraft AAA stent graft system in treating abdominal aortic aneurysms. The Incraft AAA system is under investigation through the company's multi-center, prospective, non-randomized INNOVATION study in AAA patients, according to a press release. News Well, Clinical Trials, Research & Development, Stent Graftsread more

Harvest lands expanded CE Mark for its bone marrow product

November 23, 2012 11:29 am | by Mass Device | News | Comments

Harvest Technologies Corp. receives expanded CE Mark approval for its SmartPReP2 bone marrow aspiration concentration system product for treating no-option critical limb ischemia. Plymouth, Mass.-based cellular therapy manufacturer Harvest Technologies landed expanded CE Mark approval for its bone marrow aspiration concentration system product in point-of-care cell concentrate preparation for treatment of no-option critical limb ischemia. Clinical studies used to support expanded CE Mark showed that the BMAC2 system could reduce risk for amputation as well as improve "rest pain" in patients with critical limb ischemia, according to the company. News Well, CE Mark, Orthobiologicsread more

Becton Dickinson to close the books on a $45 million antitrust lawsuit

November 23, 2012 11:29 am | by Mass Device | News | Comments

A New Jersey Judge grants preliminary approval for a $45 million settlement to resolve a years-long antitrust dispute against Becton Dickinson. Healthcare giant Becton Dickinson & Co. (NYSE:BDX) may finally close the books on a years-long lawsuit after a New Jersey judge authorized a $45 million settlement to the company's hypodermic product purchasers. Legal News, News Wellread more

FDA solicits comment on custom device review

November 23, 2012 10:29 am | by Mass Device | News | Comments

The FDA opens up for public comment its custom medical device review protocols, asking interested parties to offer perspective on a system that has had some recent snafus. The FDA is seeking public comment on its custom medical device exemption criteria following some changes implemented through the FDA Safety & Innovation Act, which was signed into law earlier this year. The proposed rules include 4 main tenets for fitting the definition of a custom medical device as well as limits on annual production and use. News Well, Food & Drug Administration (FDA), Regulatory/Complianceread more

Medbox Updates Financial Projections

November 23, 2012 9:44 am | by Bio-Medicine.Org | News | Comments

HOLLYWOOD, Calif., Nov. 23, 2012 /- Medbox, Inc. (Ticker: MDBX) ( www.medboxinc.com ), updated their financial projections for the periods through 2016. The move came after the recent votes in the states of Colorado and Washington to legalize marijuana, and a flood of requests for assistance came into Medbox from operators and potential operators in those states, looking for gu...

Advertisement

WorldRad.com, an International Subsidiary of USARAD.com, Partners with European Teleradiology Firm Direct Diagnostic Alliance

November 23, 2012 9:00 am | by The Associated Press | News | Comments

MT. LAUREL, N.J.--(BUSINESS WIRE)--Nov 23, 2012--USARAD.com announces a Joint Venture between its international subsidiary WorldRad.com division and Direct Diagnostic Alliance headquartered in Barcelona, Spain. The Joint Commission-accredited USARAD.com U.S. board-certified American Board...

Volcano Corporation Signs Agreement to Acquire Sync-Rx Ltd.

November 23, 2012 8:43 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 23, 2012 /- Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it has entered into a definitive agreement to acquire Sync-Rx Ltd., a privately-held company based in Israel that develops advan...

Mazor Robotics to Announce Third Quarter Financial Results on Tuesday, November 27, 2012

November 23, 2012 8:30 am | by The Associated Press | News | Comments

CAESAREA, Israel--(BUSINESS WIRE)--Nov 23, 2012--Mazor Robotics Ltd. (TASE: MZOR), a developer of innovative surgical robots and complementary products, today announced that it will release its financial results for the third quarter of fiscal 2012, ended September 30, on Tuesday, November 27,...

The IRS gears up to tackle Obamacare | MassDevice.com On Call

November 23, 2012 8:29 am | by Mass Device | News | Comments

The Internal Revenue Service has a hefty burden on its plate in preparing to handle a new slate of taxes and rules contained within President Barack Obama's landmark Affordable Care Act. MASSDEVICE ON CALL — The U.S. Internal Revenue Service should have its hands full in dealing with implementation of the new taxes and rules contained in the Affordable Care Act. The federal agency must handle more than 40 changes to the tax code as well as make sure appropriate recipients get new tax credits and individuals and businesses pay penalties for any non-compliance. News Well, 510(k) reforms, Medical Device Tax, On Callread more

Global Display Market Worth $164.24 Billion by 2017

November 23, 2012 8:00 am | by Bio-Medicine.Org | News | Comments

DALLAS, November 23, 2012 /- According to a new market research report, "Global Display Market (2012 - 2017) By Technology [E-Paper, OLED, LED, LCD, DLP, LCoS, Plasma], Type [Conventional, Flexible, Transparent, 3D], Applications [Consumer Appliances, Home Appliances, Automotive, Industrial, Healthcare, Others] & Geography" published by MarketsandMarkets ( www.market...

Research and Markets: Mexico Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

November 23, 2012 7:19 am | by The Associated Press | News | Comments

DUBLIN--(BUSINESS WIRE)--Nov 23, 2012--Research and Markets ( http://www.researchandmarkets.com/research/9l27mw/mexico_orthopedic ) has announced the addition of GlobalData's new report "Mexico Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip...

Endotach sues Medtronic over stent graft patents

November 23, 2012 7:00 am | by Mass Device | News | Comments

Endotach LLC sues Medtronic, alleging infringement of a pair of patents covering stent graft technology by the medical device company's Talent, Valiant and Endurant devices. Medtronic (NYSE:MDT) infringes a pair of patents licensed to Endotach LLC with 3 of its stent grafts for treating abdominal aortic aneurysms, according to a lawsuit filed by Endotach against the medtech titan. The Frisco, Texas-based company holds the exclusive license to the duo of patents from their inventor's widow, according to court documents. Legal News, News Well, Patent Infringement, Stent Graftsread more

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading